Medications for Other Chronic Obstructive Pulmonary Disease

4 results

  • anoro ellipta

    (umeclidinium bromide and vilanterol trifenatate)
    GlaxoSmithKline LLC
    ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.

  • bevespi aerosphere

    (Glycopyrrolate and formoterol fumarate)
    AstraZeneca Pharmaceuticals LP
    BEVESPI AEROSPHERE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or for asthma treatment.

  • dupixent

    (Dupilumab)
    sanofi-aventis U.S. LLC
    DUPIXENT is indicated for treating moderate-to-severe atopic dermatitis in patients 6 months and older, asthma in patients 6 years and older, chronic rhinosinusitis with nasal polyps in patients 12 and older, eosinophilic esophagitis, prurigo nodularis, inadequate COPD management, chronic spontaneous urticaria over 12, and bullous pemphigoid in adults.

  • ohtuvayre

    (ensifentrine)
    Verona Pharma, Inc.
    OHTUVAYRE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.